Author:
Abbaspour-Aghdam Sanaz,Hazrati Ali,Abdolmohammadi-Vahid Samaneh,Tahmasebi Safa,Mohseni Jafar,Valizadeh Hamed,Nadiri Mehdi,Mikaeili Haleh,Sadeghi Armin,Yousefi Mehdi,Roshangar Leila,Nikzad Behzad,Jadidi-Niaragh Farhad,Kafil Hossein Samadi,Malekpour Kosar,Ahmadi Majid
Funder
Tabriz University of Medical Sciences
Reference67 articles.
1. Anticancer potential of curcumin: preclinical and clinical studies;Aggarwal;Anticancer Res.,2003
2. Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: a double-blind, phase II randomized clinical trial;Ahmadi;Int. Immunopharm.,2019
3. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: a randomized, double‐blind, placebo‐controlled clinical trial;Ahmadi;J. Cell. Biochem.,2020
4. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease;Ahmadi;J. Cell. Physiol.,2019
5. Emerging insights into natural killer cells in human peripheral tissues;Björkström;Nat. Rev. Immunol.,2016
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献